Edlund C, Nord C E
Department of Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge University Hospital, Stockholm, Sweden.
Drugs. 1999;58 Suppl 2:65-70. doi: 10.2165/00003495-199958002-00013.
Quinolones have a selective effect on the normal human intestinal microflora. Published data on 13 different quinolone agents [ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, lomefloxacin, levofloxacin, sparfloxacin, rufloxacin, sitafloxacin (DU-6859a), gatifloxacin, trovafloxacin and moxifloxacin] show that gram-negative aerobic bacteria, especially Enterobacteriaceae, are strongly suppressed or eliminated during therapy. Gram-positive aerobic cocci are affected strongly by administration of sitafloxacin and moxifloxacin and to minor degrees by the other quinolones. Three new quinolones--gatifloxacin, trovafloxacin and moxifloxacin--are very active against anaerobic bacteria in vitro but have minor effects on the anaerobic intestinal human microflora. Similar findings have been reported for the other 10 quinolones. Thus, the quinolone antibacterials have an ecological impact on the human intestinal microflora, mainly on the enterobacteria, that should be taken into account when these agents are used for prophylaxis or treatment of gastrointestinal bacterial infections.
喹诺酮类药物对正常人体肠道微生物群具有选择性作用。关于13种不同喹诺酮类药物(环丙沙星、依诺沙星、诺氟沙星、氧氟沙星、培氟沙星、洛美沙星、左氧氟沙星、司帕沙星、芦氟沙星、西他沙星(DU-6859a)、加替沙星、曲伐沙星和莫西沙星)的已发表数据表明,革兰氏阴性需氧菌,尤其是肠杆菌科细菌,在治疗期间会受到强烈抑制或清除。革兰氏阳性需氧球菌在使用西他沙星和莫西沙星时受到强烈影响,而受其他喹诺酮类药物的影响较小。三种新型喹诺酮类药物——加替沙星、曲伐沙星和莫西沙星——在体外对厌氧菌具有很强的活性,但对人体肠道厌氧菌微生物群的影响较小。其他10种喹诺酮类药物也有类似的研究结果。因此,喹诺酮类抗菌药物对人体肠道微生物群具有生态影响,主要是对肠杆菌科细菌,在将这些药物用于预防或治疗胃肠道细菌感染时应予以考虑。